DMAA Drugs Made In America Acquisition Corp. Ordinary Shares

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

DMAA — —
Key stats
About
Industry (SIC)
BLANK CHECKS (6770)
Exchange
XNAS
Market Cap
$0.3B
List Date
2025-02-25
CIK
0002028614
Headquarters
New York, NY

Drugs Made In America Acquisition Corp is a blank check company.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'25'26Avg
Jan--0.48%0.48%
Feb0.10%0.19%0.15%
Mar0.60%0.19%0.40%
Apr0.60%0.29%0.44%
May0.40%0.38%0.39%
Jun0.49%0.47%0.48%
Jul0.74%0.66%0.70%
Aug-0.16%0.42%0.13%
Sep0.10%1.16%0.63%
Oct0.49%0.00%0.24%
Nov0.05%0.05%*0.05%
Dec0.23%--0.23%
Total3.70%4.37%4.03%
* Only 2 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $10.87
SMA 50: $10.84
SMA 200: $10.60
Current: $10.89
EMA 12: $10.88
EMA 26: $10.87
MACD: 0.0146 | Signal: -0.0020
BULLISH
ADX (14): 14.66
RANGE
+DI: 28.58
−DI: 23.10

Momentum Oscillators

RSI (14): 64.69
NEUTRAL
Stoch %K: 88.89
Stoch %D: 82.10
Williams %R: 0.00

Volume & Volatility

BB Upper: $10.90
BB Lower: $10.85
NEUTRAL
OBV: 12,882,936
Vol SMA 20: 14,668
Vol ROC: -94.56%
ATR: $0.01
True Range: $0.01
HV 20: 1.0%
HV 30: 2.0%
HV 60: 1.8%

Data Summary

Data Points: 383
Last Updated:
Date Range: 2025-02-25T00:00:00 – 2026-11-06T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL (6/10)

Key Drivers:

  • Technical signals indicate a weak trend, with RSI in neutral territory
  • Momentum oscillators suggest a potential reversal or consolidation
  • Bollinger Bands signal is neutral, indicating no strong buying or selling pressure

Primary Risks:

  • Volatility regime shift to higher volatility could lead to increased risk
  • Potential for unexpected news or events that could impact stock price

Investment Thesis: DMAA appears to be in a consolidation phase, with no clear directional bias. The stock's technical and momentum indicators suggest a potential reversal or mean reversion. However, the absence of recent news headlines and earnings data limits our ability to assess sentiment and catalysts.

Recent News Sentiment Impact: N/A (no recent news available)

Technical Analysis

Trend Direction: Weak Trend (short-term and medium-term), Consolidation (long-term)

Support/Resistance Levels:

  • SMA 20: $10.59
  • SMA 50: $10.54
  • SMA 200: $10.38
  • Upper Bollinger Band: $10.62

Momentum Signals:

  • RSI: 65.32 (neutral)
  • MACD: Bullish (0.02 / Signal: -0.00 / Histogram: 0.02)
  • Stochastic %K and %D are near overbought levels

Volume Analysis:

  • Volume SMA 20: 31203.35
  • On-Balance Volume (OBV): 12590751.73
  • Volume Rate of Change: 3990.96%

News & Sentiment Analysis

Recent Headlines Summary: N/A (no recent news available)

Sentiment Assessment: N/A (no recent news available)

Catalyst Identification: N/A (no earnings or options data available)

Market Narrative: The absence of recent news headlines and earnings data limits our ability to assess sentiment and catalysts.

Risk & Volatility Assessment

Beta Interpretation: Beta -0.01 (vs SPY) - stock moves opposite to market

Volatility Regime: Historical volatility is relatively low, with HV20 2.2% and HV30 2.0%

Options Market Signals: N/A (no options data available)

Downside Protection: Support levels are provided by SMA 50 and SMA 200, while the Upper Bollinger Band offers resistance.

Market Context & Positioning

Sector Performance: N/A (stock not part of a specific sector)

Institutional Activity: N/A (no recent volume or trading data available)

Correlation Analysis: Stock moves opposite to market (beta -0.01 vs SPY)

Relative Valuation: N/A (no valuation metrics available)

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $10.59
  • SMA 50: $10.54
  • SMA 200: $10.38
  • Upper Bollinger Band: $10.62

Breakout/Breakdown Levels: N/A (no clear levels identified)

Time-Sensitive Catalysts: Earnings date not available

Risk Management: Stop-loss levels and position sizing considerations will depend on individual risk tolerance.

Note: This report is based on the provided data and does not include buy/sell advice. It's essential to consider additional factors, such as fundamental analysis and market context, before making investment decisions.

Generated
News
All DMAA news →

DMAA Options Activity & IV Rank

Loading options activity...
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: -0.0010
Alpha: 6.44%
Correlation: -0.0068
R-Squared: 0.0%
Stock Volatility: 2.0%
Market Volatility: 13.4%

Analysis Details

Benchmark: SPY
Data Points: 214
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Beta & Alpha Over Time

DMAA Institutional Ownership (13F)

Filings for 2026-06-30 · 3 already for 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

23 filers11,912,303 shares$124.43M value
# Filer Shares Value % of Total % of Float Period
1 Karpus Management, Inc. 2,507,817 $26.71M 21.46% — 2026-06-30
2 MIZUHO SECURITIES USA LLC 2,000,000 $20.90M 16.80% — 2026-06-30
3 Polar Asset Management Partners Inc. 1,146,000 $12.20M 9.81% — 2026-06-30
4 GLAZER CAPITAL, LLC 999,899 $10.65M 8.56% — 2026-06-30
5 WOLVERINE ASSET MANAGEMENT LLC 851,989 $9.27M 7.45% — 2026-09-30
6 HIGHBRIDGE CAPITAL MANAGEMENT LLC 809,054 $8.62M 6.92% — 2026-06-30
7 First Trust Capital Management L.P. 786,459 $8.56M 6.88% — 2026-09-30
8 HEIGHTS CAPITAL MANAGEMENT, INC 648,083 $6.90M 5.55% — 2026-06-30
9 Westchester Capital Management, LLC 581,790 $6.20M 4.98% — 2026-06-30
10 ARISTEIA CAPITAL, L.L.C. 350,000 $3.73M 3.00% — 2026-06-30
11 SONA ASSET MANAGEMENT (US) LLC 162,795 $1.73M 1.39% — 2026-06-30
12 Clear Street Group Inc. 382,440 $1.65M 1.32% — 2026-06-30
13 RLH Capital LLC 115,606 $1.23M 0.99% — 2026-06-30
14 Logan Stone Capital, LLC 109,959 $1.17M 0.94% — 2026-06-30
15 TORONTO DOMINION BANK 100,000 $1.06M 0.86% — 2026-06-30
16 Meteora Capital, LLC 97,837 $1.04M 0.84% — 2026-06-30
17 Quarry LP 65,551 $698.12K 0.56% — 2026-06-30
18 Geode Capital Management, LLC Custodian 60,382 $656.96K 0.53% — 2026-09-30
19 JPMorgan Chase & Co Custodian 49,891 $531.34K 0.43% — 2026-06-30
20 Dakota Wealth Management 36,400 $387.66K 0.31% — 2026-06-30
21 Lineage Point Capital LP 31,840 $339.10K 0.27% — 2026-06-30
22 HRT FINANCIAL LP 18,483 $196.00K 0.16% — 2026-06-30
23 Morgan Stanley Custodian 28 $298 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

DMAA Board & Officers

As of SEC filings through Feb 18, 2025
The company's insiders have not filed since Feb 18, 2025; this reflects that date.

Directors 3

10% owners 2

Changes in the last 10 years (11)
Feb 28, 2026The company announced the departure of Lynn Stockwell from the board in an SEC filing
Feb 28, 2026The company announced the departure of Lynn Stockwell as Chief Executive Officer and Executive Chair of the Board in an SEC filing
Oct 8, 2025The company announced the departure of Glenn C. Worman as CFO in an SEC filing
Jan 7, 2025Sridhar G. Prasad became a director
Jan 7, 2025Myron W. Shulgan became a director
Jan 7, 2025Lynn Stockwell became a director
Jan 7, 2025Lynn Stockwell became a 10% owner
Jan 7, 2025Lynn Stockwell became Chief Executive Officer and Executive Chair of the Board
Jan 7, 2025Glenn C. Worman became CFO
Jan 7, 2025Drugs Made In America Acquisition LLC became a 10% owner
Jan 7, 2025Catherine Do became a director
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
Recent SEC Filings
Latest: 2026-10-21
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-10-21 Material agreement · Other events EDGAR
2026-09-14 Material agreement EDGAR
2026-07-20 Material agreement EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-08-14 0001213900-26-090035 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

DMAA vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
CCCX Churchill Capital Corp X Class A Ordinar $711M — — −19.1% —
DMII Drugs Made In America Acquisition II Cor $650M — — +3.3% —
EVAC EQV Ventures Acquisition Corp. II $606M — — +3.4% —
BCSS Bain Capital GSS Investment Corp. $598M — — +1.3% —
CEPF Cantor Equity Partners IV, Inc. Class A $589M — — −0.3% —
CXII Churchill Capital Corp XII Class A Ordin $575M — — +2.8% —
AEXA American Exceptionalism Acquisition Corp $526M — — −7.3% 17
CAEP Cantor Equity Partners III, Inc. Class A $526M — — +46.9% —
DMAA Drugs Made In America Acquisition Corp. $264M — — +4.9% —
Peer median $593M — — +2.0% 17

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.